ID   UHG-NP
AC   CVCL_A436
SY   UHGNP
DR   Cosmic; 1109109
DR   Cosmic; 1518081
DR   Cosmic; 1526658
DR   Cosmic; 1543777
DR   GEO; GSM692876
DR   Wikidata; Q54990144
RX   PubMed=7838528;
RX   PubMed=9283597;
RX   PubMed=9516836;
RX   PubMed=11319804;
RX   PubMed=20655465;
RX   PubMed=22213050;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
RX   PubMed=7838528;
RA   Cheng N.C., Van Roy N., Chan A., Beitsma M., Westerveld A.,
RA   Speleman F., Versteeg R.;
RT   "Deletion mapping in neuroblastoma cell lines suggests two distinct
RT   tumor suppressor genes in the 1p35-36 region, only one of which is
RT   associated with N-myc amplification.";
RL   Oncogene 10:291-297(1995).
//
RX   PubMed=9283597; DOI=10.1016/S0165-4608(96)00362-7;
RA   Van Roy N., Jauch A., Van Gele M., Laureys G., Versteeg R.,
RA   De Paepe A., Cremer T., Speleman F.;
RT   "Comparative genomic hybridization analysis of human neuroblastomas:
RT   detection of distal 1p deletions and further molecular genetic
RT   characterization of neuroblastoma cell lines.";
RL   Cancer Genet. Cytogenet. 97:135-142(1997).
//
RX   PubMed=9516836; DOI=10.1016/S0959-8049(97)00319-5;
RA   Van Roy N., Laureys G., Van Gele M., Opdenakker G., Miura R.,
RA   van der Drift P., Chan A., Versteeg R., Speleman F.;
RT   "Analysis of 1;17 translocation breakpoints in neuroblastoma:
RT   implications for mapping of neuroblastoma genes.";
RL   Eur. J. Cancer 33:1974-1978(1997).
//
RX   PubMed=11319804; DOI=10.1002/gcc.1130;
RA   Spieker N., Beitsma M., Van Sluis P., Chan A., Caron H.N., Versteeg R.;
RT   "Three chromosomal rearrangements in neuroblastoma cluster within a
RT   300-kb region on 1p36.1.";
RL   Genes Chromosomes Cancer 31:172-181(2001).
//
RX   PubMed=20655465; DOI=10.1016/j.cell.2010.06.004; PMCID=PMC2913027;
RA   Holzel M., Huang S.-D., Koster J., Ora I., Lakeman A., Caron H.N.,
RA   Nijkamp W., Xie J., Callens T., Asgharzadeh S., Seeger R.C.,
RA   Messiaen L.M., Versteeg R., Bernards R.;
RT   "NF1 is a tumor suppressor in neuroblastoma that determines retinoic
RT   acid response and disease outcome.";
RL   Cell 142:218-229(2010).
//
RX   PubMed=22213050; DOI=10.1002/ijc.27415; PMCID=PMC3757132;
RA   Gawecka J.E., Geerts D., Koster J., Caliva M.J., Sulzmaier F.J.,
RA   Opoku-Ansah J., Wada R.K., Bachmann A.S., Ramos J.W.;
RT   "PEA15 impairs cell migration and correlates with clinical features
RT   predicting good prognosis in neuroblastoma.";
RL   Int. J. Cancer 131:1556-1568(2012).
//